Trending now

Accela Announces Record Quarter of Growth in Its Core Business with New…

Absinthe Market to Reach $44.3 Bn, Globally, by 2026 at 3.4% CAGR,…

Privy Peach Announces Increased Value in Their All-Natural Intimate Oil

Driven Deliveries To Acquire Humboldt Heritage Inc

BPCM Announces Launch of Cannabis Division

LOSS NOTICE: ROSEN, A TOP RANKED LAW FIRM, Reminds Trulieve Cannabis Corp.…

Cannabidiol Nutraceuticals Market Size Worth $17.4 Billion By 2026: Grand View Research,…

THE DATA INITIATIVE Welcomes Former Wells Fargo & Co. Executive Jim Richards,…

KALY- Kali-Extracts Anticipates Gross Margin Increase from Cannabis Biopharmaceutical Technology Consolidation

Gold Flora Announces Working Partnership with Silo Distribution

Tag : company

CCT Impact

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies to Acquire Leading Oncology Research and Development Company Sapphire Biotech, Inc.

CCT IMPACT Agent
by CCT IMPACT Agent039
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has signed a binding term sheet to acquire leading oncology research and development company Sapphire......
CCT Impact

Canopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant

CCT IMPACT Agent
by CCT IMPACT Agent061
Canopy Rivers Inc. (“Canopy Rivers“) (TSX: RIV, OTC: CNPOF) portfolio company BioLumic Ltd. (“BioLumic“) has received approval from the New Zealand Ministry of Health to apply its proprietary ultraviolet (“UV“) light technology to medical cannabis. While BioLumic’s approach has been successful in increasing yields in certain crops, such as strawberries,......
Market Watch

FDA, FTC warn company marketing unapproved cannabidiol products with unsubstantiated claims to treat teething and ear pain in infants, autism, ADHD, Parkinson’s and Alzheimer’s disease

CCT IMPACT Agent
by CCT IMPACT Agent0264
Today, the U.S. Food and Drug Administration and the Federal Trade Commission posted a joint warning letter to Rooted Apothecary LLC, of Naples, Florida, for illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat teething pain and ear aches in infants, autism, attention-deficit/hyperactivity disorder (ADHD), as well......